Patricia M. Danzon

The Wharton School, Univ. of Pennsylvania

Celia Moh Professor

3641 Locust Walk

Colonial Penn Center

Philadelphia, PA 19104-6358

United States

University of Pennsylvania - The Wharton School

Celia Moh Professor

Philadelphia, PA 19104-6367

United States

  • The Wharton School, Univ. of Pennsylvania

  • University of Pennsylvania - The Wharton School

SCHOLARLY PAPERS

18

DOWNLOADS
Rank 20,778

SSRN RANKINGS

Top 20,778

in Total Papers Downloads

4,937

TOTAL CITATIONS
Rank 6,933

SSRN RANKINGS

Top 6,933

in Total Papers Citations

72

Scholarly Papers (18)

Actions:
Email selected abstracts
1.

Mergers and Acquisitions in the Pharmaceutical and Biotech Industries

Downloads 1,902 (17,893)
Citation 9

Mergers and Acquisitions in the Pharmaceutical and Biotech Industries

Number of pages: 43 Posted: 14 Nov 2003
Patricia M. Danzon, Patricia M. Danzon, Andrew Joel Epstein and Sean Nicholson
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania, Yale University - School of Public Health and Cornell University - Department of Policy Analysis & Management (PAM)
Downloads 1,493 (25,476)
Citation 5

Abstract:

Loading...

Mergers and Acquisitions in the Pharmaceutical and Biotech Industries

NBER Working Paper No. w10536
Number of pages: 46 Posted: 17 Jun 2004 Last Revised: 17 Apr 2022
Patricia M. Danzon, Patricia M. Danzon, Andrew Joel Epstein and Sean Nicholson
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania, Yale University - School of Public Health and Cornell University - Department of Policy Analysis & Management (PAM)
Downloads 409 (143,710)
Citation 4

Abstract:

Loading...

2.

Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents

Number of pages: 35 Posted: 16 Jul 2003
Patricia M. Danzon, Patricia M. Danzon and Adrian Towse
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Office of Health Economics
Downloads 942 (50,406)
Citation 29

Abstract:

Loading...

differential pricing, pharmaceuticals, developing countries, parallel trade, Global Fund

3.

The Neglected Concern of Firm Size in Pharmaceutical Mergers

84 Antitrust Law Journal 487 (2022), Rutgers Law School Research Paper No. Forthcoming
Number of pages: 34 Posted: 18 Feb 2021 Last Revised: 22 Jun 2022
Patricia M. Danzon, Patricia M. Danzon and Michael A. Carrier
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Rutgers Law School
Downloads 563 (99,550)

Abstract:

Loading...

pharmaceutical industry, mergers, acquisitions, antitrust, divestitures

4.

Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?

Number of pages: 7 Posted: 25 Aug 2015
Martina Garau, Adrian Towse, Patricia M. Danzon and Patricia M. Danzon
Office of Health Economics, Office of Health Economics and University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania
Downloads 218 (279,659)
Citation 2

Abstract:

Loading...

5.

Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand

NBER Working Paper No. w10007
Number of pages: 48 Posted: 05 Oct 2003 Last Revised: 06 Nov 2022
Patricia M. Danzon, Patricia M. Danzon and Jonathan Ketcham
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Arizona State University (ASU) - Marketing Department
Downloads 197 (307,400)

Abstract:

Loading...

6.

Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances

NBER Working Paper No. w9615
Number of pages: 40 Posted: 11 Apr 2003 Last Revised: 10 Oct 2022
Patricia M. Danzon, Patricia M. Danzon, Sean Nicholson and Nuno Sousa Pereira
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania, Cornell University - Department of Policy Analysis & Management (PAM) and University of Pennsylvania - The Wharton School
Downloads 178 (337,070)
Citation 7

Abstract:

Loading...

7.

Firm Size and Pharmaceutical Mergers: A Cross-National, Cross-Sector Perspective

Concurrences No.3-2021, Forthcoming
Number of pages: 21 Posted: 14 Jul 2021
Patricia M. Danzon and Patricia M. Danzon
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania
Downloads 171 (349,141)

Abstract:

Loading...

pharmaceutical industry, mergers, acquisitions, antitrust, divestitures

8.

Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality

NBER Working Paper No. w9007
Number of pages: 47 Posted: 21 Jun 2002 Last Revised: 13 Aug 2022
Sean Nicholson, Patricia M. Danzon, Patricia M. Danzon and Jeffrey McCullough
Cornell University - Department of Policy Analysis & Management (PAM), University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and University of Pennsylvania - The Wharton School
Downloads 167 (356,298)
Citation 3

Abstract:

Loading...

9.

The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

NBER Working Paper No. w9874
Number of pages: 42 Posted: 08 Aug 2003 Last Revised: 26 Jun 2022
Patricia M. Danzon, Patricia M. Danzon, Y. Richard Wang and Liang Leon Wang
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania, AstraZeneca Pharmaceuticals - Public Policy Department and University of Pennsylvania - Statistics Department
Downloads 154 (381,513)
Citation 13

Abstract:

Loading...

10.

Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context

NBER Working Paper No. w18593
Number of pages: 23 Posted: 07 Dec 2012 Last Revised: 22 Apr 2023
Patricia M. Danzon, Patricia M. Danzon, Adrian Towse and Jorge Mestre-Ferrandiz
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania, Office of Health Economics and Office of Health Economics
Downloads 86 (583,910)

Abstract:

Loading...

11.

Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future

The 13th Annual Herbert Lourie Memorial Lecture on Health Policy, 2002
Number of pages: 29 Posted: 25 Apr 2011
Patricia M. Danzon, Patricia M. Danzon and Stephen Soumerai
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Harvard University - Department of Ambulatory Care and Prevention
Downloads 86 (583,910)

Abstract:

Loading...

12.

Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets

NBER Working Paper No. w17226
Number of pages: 44 Posted: 21 Jul 2011 Last Revised: 26 Jan 2023
Patricia M. Danzon, Patricia M. Danzon and Michael Furukawa
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and affiliation not provided to SSRN
Downloads 85 (588,100)

Abstract:

Loading...

13.

Vaccine Supply: Effects of Regulation and Competition

NBER Working Paper No. w17205
Number of pages: 46 Posted: 11 Jul 2011 Last Revised: 07 Jul 2023
Patricia M. Danzon, Patricia M. Danzon and Nuno Sousa Pereira
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and University of Pennsylvania - The Wharton School
Downloads 72 (645,608)

Abstract:

Loading...

14.

Effects of Regulation on Drug Launch and Pricing in Interdependent Markets

NBER Working Paper No. w14041
Number of pages: 61 Posted: 02 Jun 2008 Last Revised: 15 May 2022
Patricia M. Danzon, Patricia M. Danzon and Andrew Joel Epstein
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Yale University - School of Public Health
Downloads 69 (660,154)

Abstract:

Loading...

15.

Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement

NBER Working Paper No. w17174
Number of pages: 33 Posted: 05 Jul 2011 Last Revised: 05 Jun 2023
Patricia M. Danzon, Patricia M. Danzon, Andrew Mulcahy and Adrian Towse
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania, University of Pennsylvania - The Wharton School and Office of Health Economics
Downloads 47 (787,400)
Citation 9

Abstract:

Loading...

16.

Insurance and New Technology: From Hospital to Drugstore

Posted: 09 Oct 2001
Patricia M. Danzon, Patricia M. Danzon and Mark V. Pauly
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and University of Pennsylvania - Health Care Systems Department

Abstract:

Loading...

17.

Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance

Posted: 12 Sep 2000
Scott E. Harrington, Patricia M. Danzon and Patricia M. Danzon
University of Pennsylvania - Wharton School and University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania

Abstract:

Loading...

18.

Does Regulation Drive Out Competition in Pharmaceutical Markets?

Posted: 11 Jul 2000
Patricia M. Danzon, Patricia M. Danzon and Li-Wei Chao
University of Pennsylvania - The Wharton SchoolThe Wharton School, Univ. of Pennsylvania and Population Studies Center

Abstract:

Loading...